Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
At Best, FDA Will Carry Out Only Half Of Domestic Surveillance Inspections In FY 2021, Report Says
Agency vows to create Inspectional Affairs Council, modernize its regulatory oversight approach
May 05 2021
•
By
Shawn M. Schmitt
More from Regulation
More from Policy & Regulation